CN114836362A - Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system - Google Patents
Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system Download PDFInfo
- Publication number
- CN114836362A CN114836362A CN202210713019.5A CN202210713019A CN114836362A CN 114836362 A CN114836362 A CN 114836362A CN 202210713019 A CN202210713019 A CN 202210713019A CN 114836362 A CN114836362 A CN 114836362A
- Authority
- CN
- China
- Prior art keywords
- seq
- esar
- escherichia coli
- esai
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 37
- 101150015947 fimH gene Proteins 0.000 title claims abstract description 31
- 238000000855 fermentation Methods 0.000 title claims abstract description 22
- 230000004151 fermentation Effects 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 19
- 230000018612 quorum sensing Effects 0.000 title abstract description 17
- 230000033228 biological regulation Effects 0.000 title abstract description 12
- 239000013612 plasmid Substances 0.000 claims abstract description 44
- 241000894006 Bacteria Species 0.000 claims abstract description 37
- 101100445598 Pantoea stewartii subsp. stewartii esaI gene Proteins 0.000 claims abstract description 37
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 16
- 238000010353 genetic engineering Methods 0.000 claims abstract description 11
- 241000672609 Escherichia coli BL21 Species 0.000 claims abstract description 6
- 101100389725 Pantoea stewartii subsp. stewartii esaR gene Proteins 0.000 claims description 55
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 239000012634 fragment Substances 0.000 claims description 29
- 108020004414 DNA Proteins 0.000 claims description 28
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 23
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 238000010367 cloning Methods 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 4
- 108700008625 Reporter Genes Proteins 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 229930003270 Vitamin B Natural products 0.000 claims description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 3
- SCVOEYLBXCPATR-UHFFFAOYSA-L manganese(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O SCVOEYLBXCPATR-UHFFFAOYSA-L 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000019156 vitamin B Nutrition 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 108010054624 red fluorescent protein Proteins 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 abstract description 9
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 238000009792 diffusion process Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 230000008054 signal transmission Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 239000002609 medium Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- 230000032770 biofilm formation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000000137 annealing Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 101150040799 luxI gene Proteins 0.000 description 4
- 101150016512 luxR gene Proteins 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000003235 crystal violet staining Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 101150043770 fimA gene Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- XNCMOUSLNOHBKY-UHFFFAOYSA-H iron(3+);trisulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O XNCMOUSLNOHBKY-UHFFFAOYSA-H 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- JFTUSFFYSRNFBA-UHFFFAOYSA-N 3-amino-5-nitrosalicylic acid Chemical compound NC1=CC([N+]([O-])=O)=CC(C(O)=O)=C1O JFTUSFFYSRNFBA-UHFFFAOYSA-N 0.000 description 1
- 241000607620 Aliivibrio fischeri Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 241000932831 Pantoea stewartii Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000193446 Thermoanaerobacterium thermosaccharolyticum Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 101150031647 esaI gene Proteins 0.000 description 1
- 101150009888 esaR gene Proteins 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000008560 physiological behavior Effects 0.000 description 1
- 101150014100 pilA gene Proteins 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091006107 transcriptional repressors Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for improving immobilized fermentation of escherichia coli by applying pilus adhesion protein fimH to a quorum sensing dynamic regulation and control system, wherein escherichia coli genetic engineering bacteria introduce pUC19-PJ23119-MCS plasmid containing esaI/R system into escherichia coli BL21, and combine the plasmid with adhesion gene fimH. The invention combines the adhesion gene fimH related to the colibacillus film formation with the quorum sensing system esaI/R for the first time, controls the formation, decomposition and diffusion of the biological film through the signal transmission among quorum sensing signal molecules, establishes a specific regulation and control mode, accurately regulates and controls the formation process of the biological film in the fermentation process, strengthens the formation of the biological film in the early and middle stages of the fermentation, weakens the decomposition and diffusion in the later stage, and improves the immobilization efficiency and the catalytic efficiency of the biological film.
Description
Technical Field
The invention relates to the field of biology, in particular to a method for improving immobilized fermentation of escherichia coli by applying pilus adhesion protein fimH to a quorum sensing dynamic regulation and control system.
Background
Biofilms (bifilms) are a form of microbial community in nature. The microorganisms gather together and secrete organic substances, such as polysaccharides, to cover the surface of the microorganisms, thereby forming a film-like substance. The microorganisms can better adapt to the external environment by forming the colony structure, and resist factors unfavorable for survival. In the medical field, the drug resistance of the bacteria is improved because the pathogenic bacteria often form a biological membrane, and the research on the biological membrane lasts for a long time. In the field of industrial fermentation applications, the mechanism of biofilm formation is relatively poorly studied. In particular to the molecular research aiming at the fermentation characteristics of the immobilized cells.
Adhesion proteins are a class of adhesion proteins that are widely found in gram bacteria. In gram-negative bacteria, the cell movement organ, which is composed of adhesion proteins, is called pilus. The role of these pili is mainly responsible for adhesion between bacterial cells, bacteria and non-biological surfaces, and is associated with biofilm formation and DNA transfer, among other things. The Escherichia coli has various types of pili, and a great deal of research shows that the I-type pili of the Escherichia coli promotes the biofilm formation in the process of forming the biofilm by the Escherichia coli, plays an important role in the reversible and non-reversible stages of the biofilm formation stage, and can enhance the adhesion characteristics among Escherichia coli cells and between cells and non-biological surfaces. The main key genes of the I-type pilus are regulated and controlled by a fim family, and comprise 9 genes such as fimA, fimH and the like, the fimH gene is the adhesin of the I-type pilus and is responsible for the adhesion with a non-biological surface, the I-type pilus also has an important function on the formation of an escherichia coli biofilm, and the fimA gene and the fimH gene are key genes for the formation of the escherichia coli biofilm.
Quorum Sensing (QS) is a bacterial cell-to-cell communication system, where microorganisms sense changes in the density of bacterial populations through secretion of diffusible small molecule signals, thereby causing coordinated expression of a set of specific genes at the transcriptional level. This communication allows the bacteria to express different physiological behaviors including regulation of bioluminescence, biofilm formation, toxin production, spore formation, and the like.
With the intensive research on quorum sensing action mechanism, the biological characteristic can be used for developing a cell density-dependent self-induced dynamic regulation tool. In E.coli, lacking genes responsible for the synthesis of AHLs with functions similar to LuxI, it is not able to produce AHL signal molecules by itself, but they encode LuxR homologous proteins and therefore can sense and respond to AHLs produced by other bacteria.
The AHL-mediated quorum sensing systems currently most studied and most widely used are mainly the luxI/luxR system from Vibrio fischeri and the esaI/esaR system from bacterial wilt disease of maize. Among gram-negative bacteria, the QS system, consisting of the luxI/luxR bi-component, is the most widely studied. Whereas the esaI/esaR system is homologous to the luxI/luxR system and originates from the maize pathogen Pantoea stewartii subspecies. Unlike most LuxR homologues, esaR can act as both a transcriptional activator and repressor, independent of whether binding to AHL signaling molecule occurs. In addition, Pesar is a native promoter that is repressed by esaR, and Pesas is a native promoter that is activated by esaR. At low cell densities, the cells produce less AHL signaling molecules and esaR binds to its target DNA sequence (esa box), turning on expression of the genes downstream of the PesaS promoter and turning off expression of the genes downstream of the PesaR promoter. At high cell densities, the cells produced more AHL signaling molecules and esaR released esa box binding to AHL, at which time the promoter PesaR was open and PesaS was closed.
Disclosure of Invention
The invention aims to: the technical problem to be solved by the invention is to provide a genetically engineered Escherichia coli strain containing quorum-sensing dynamic control biofilm formation, aiming at the defects of the prior art.
The technical problem to be solved by the invention is to provide a method for constructing the plasmid contained in the escherichia coli genetic engineering bacteria.
The invention further aims to solve the technical problem of providing the application of the escherichia coli genetic engineering bacteria.
The invention idea is as follows: the esaI/esaR system is homologous with the luxI/luxR system, and has a quorum sensing system with a bidirectional regulation function, and the adhesion gene fimH is proved to promote the formation of an escherichia coli biomembrane, so that the invention utilizes the fimH applied to the esaI/esaR system to realize the purpose of dynamic regulation.
In order to solve the first technical problem, the invention discloses an escherichia coli genetic engineering bacterium, wherein a pUC19-PJ23119-MCS plasmid containing an esaI/R system is introduced into escherichia coli BL21, and is combined with an adhesion gene fimH to be applied to improving the escherichia coli film forming amount and further improving the fermentation efficiency in immobilized fermentation.
Wherein, the gene contained in the esaI/R system is a transcription regulation factor with the nucleotide sequence respectively shown as SEQ ID NO.1 and SEQ ID NO. 2: esaI, esaR; the nucleotide sequences of the promoter are respectively shown as SEQ ID NO.3 and SEQ ID NO. 4: p esaS 、P esaR (ii) a The nucleotide sequences of the reporter genes are respectively shown as SEQ ID NO.5 and SEQ ID NO. 6: red fluorescent protein mCherry, green fluorescent protein EGFP.
Wherein the nucleotide sequence of fimH is shown as SEQ ID NO. 7.
In order to solve the second technical problem, the invention discloses a method for constructing the escherichia coli genetic engineering bacteria, which comprises the following steps:
(1) amplifying to obtain esaI and esaR genes by using pseudomonas aeruginosa genome DNA as a template; the gene P is synthesized by general biosynthesis esaS 、P esaR The PUC19 plasmid is used as a template to obtain P through amplification esaS 、P esaR A gene; amplifying by taking a plasmid pET28a-mCherry as a template to obtain an mCheerry gene; amplifying by taking the plasmid pET-28a-EGFP as a template to obtain an EGFP gene;
(2) taking the fragment obtained in the step (1) as a template, and carrying out overlap PCR amplification to obtain an esaI + esaR fragment and P esaS + fimH + mCherry fragment, P esaR + an EGFP fragment;
(3) cloning the gene fragment obtained in the step (2) between Hind III and Sac I restriction sites of plasmid pUC19-PJ23119-MCS to obtain recombinant plasmid pUC19-PJ23119-MCS-esaI/R, wherein the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 8;
(4) transforming the recombinant plasmid obtained in the step (3) into an escherichia coli T1 competence, and extracting, purifying and recovering the recombinant plasmid from escherichia coli T1;
(5) and (3) transforming the recombinant plasmid extracted in the step (4) into the competence of escherichia coli BL21 to obtain the escherichia coli genetic engineering bacteria.
In the step (1), primers for amplifying esaI and esaR genes are esaI-F, esaI-R, esaR-F, esaR-R with nucleotide sequences shown as SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO.14 respectively.
In step (1), P is amplified esaS 、P esaR The primers of the gene are P with nucleotide sequences shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO.18 respectively esaS -F、P esaS -R、P esaR -F、P esaR -R。
In the step (1), primers for amplifying mCherry and EGFP genes are mChery-F, mCherry-R, EGFP-F, EGFP-R with nucleotide sequences shown as SEQ ID No.19, SEQ ID No.20, SEQ ID No.21 and SEQ ID No.22 respectively.
In order to solve the third technical problem, the invention discloses application of the large escherichia coli genetic engineering bacteria in xylanase production.
The xylanase is produced by replacing xylanase gene with nucleotide sequence shown in SEQ ID NO.23 to EGFP gene position in large Escherichia coli genetic engineering bacteria, and inoculating the bacteria to fermentation culture medium for fermentation.
Wherein the fermentation medium comprises 30g/L of glucose, 0.8g/L of sodium chloride, 20-22g/L of ammonium sulfate, 2g/L of anhydrous potassium dihydrogen phosphate, 0.8g/L of magnesium sulfate heptahydrate, 0.02g/L of manganese sulfate pentahydrate, 0.02g/L of ferric sulfate heptahydrate, 10.002g/L of vitamin B, 1g/L of yeast powder and 15-30g/L of calcium carbonate.
Has the advantages that: compared with the prior art, the invention has the following advantages:
the invention combines the adhesion gene fimH related to the colibacillus film formation with the quorum sensing system esaI/R for the first time, controls the formation, decomposition and diffusion of the biological film through the signal transmission among quorum sensing signal molecules, establishes a specific regulation and control mode, accurately regulates and controls the formation process of the biological film in the fermentation process, strengthens the formation of the biological film in the early and middle stages of the fermentation, weakens the decomposition and diffusion in the later stage, and improves the immobilization efficiency and the catalytic efficiency of the biological film.
Drawings
The foregoing and/or other advantages of the invention will become further apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings.
FIG. 1 shows fimH, esaI, esaR, P in example 1 esaS 、P esaR Agarose gel electrophoresis of genes mCherry and EGFP.
FIG. 2 depicts the esaI + esaR fragment, P, after OVERLAP in example 1 esaS + fimH + mCherry fragment and P esaR FIG. agarose gel electrophoresis of the EGFP fragment.
FIG. 3 is a schematic diagram of the construction of a recombinant expression plasmid in example 1.
FIG. 4 is a PCR scheme of plasmid-transformed colonies in example 1.
FIG. 5 is a graph showing the results of fluorescence microscopy in example 2.
FIG. 6 is a graph showing the results of fluorescence intensity detection by the microplate reader in example 3.
FIG. 7 is a graph showing the results of the crystal violet staining experiment in example 4.
FIG. 8 is a schematic diagram showing the results of the enzyme activity assay in example 5.
Detailed Description
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
In the following embodiment, the Escherichia coli strain selected for the present invention is BL21, and Pseudomonas aeruginosa for the present invention is ATCC 15692.
Example 1: construction of the target Strain
First, amplification of target Gene
(1) Using the original genome of escherichia coli as a template, and using fimH-F, fimH-R (sequences are respectively shown as SEQ ID NO.9 and SEQ ID NO. 10) as a primer for amplification by using common PCR to obtain fimH; using pseudomonas aeruginosa genome DNA as a template, and using common PCR to amplify by using esaI-F, esaI-R, esaR-F, esaR-R (sequences are respectively shown as SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO. 14) as primers to obtain esaI and esaR; the gene P is synthesized by general biosynthesis esaS 、P esaR The pUC19 plasmid was used as a template, and P was used as a template in the conventional PCR esaS -F、P esaS -R、P esaR -F、P esaR -R (the sequences are respectively shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO. 18) is used as a primer for amplification to obtain P esaS 、P esaR A gene; using plasmid pET28a-mCherry as a template, and using a common PCR to amplify by using mCherry-F, mCherry-R (sequences are respectively shown as SEQ ID NO.19 and SEQ ID NO. 20) as a primer to obtain a reporter gene mCheerry; the reporter gene EGFP is obtained by using plasmid pET-28a-EGFP as a template and EGFP-F, EGFP-R (sequences are respectively shown as SEQ ID NO.21 and SEQ ID NO. 22) as a primer through common PCR (polymerase chain reaction).
The PCR reaction system is shown in Table 1 below, and the reaction conditions are as follows: pre-denaturation at 95 ℃ for 4 min; denaturation at 94 ℃ for 10 s; annealing at 60 ℃ for 30 s; extending for 2min at 68 ℃; degeneration and regressionThe three steps of fire and extension are circulated for 35 times; further extension was carried out at 68 ℃ for 10 min. Wherein the annealing temperature depends on the Tm value of the primer, and the extension time at 68 ℃ depends on the length of the amplified fragment (1 kb/min). After the PCR was completed, the product was subjected to agarose gel electrophoresis, as shown in FIG. 1, and the objective genes fimH, esaI, esaR, P were recovered by cutting the gel esaS 、P esaR 、mCherry、EGFP。
TABLE 1 PCR reaction System
(2) Using the esaI gene and the esaR gene obtained in the step (1) as templates, using esaI-F as an upper primer and esaR-R as a lower primer, and amplifying by using an overlap PCR technology to obtain an esaI + esaR fragment; with P obtained in step (1) esaS The gene, fimH gene and mCherry gene are used as templates and P is used esaS F is an upper primer, mchery-R is a lower primer, and P is obtained by applying overlap PCR technology to amplify esaS + fimH + mCherry fragment; with P obtained in step (1) esaR Gene and EGFP gene as template, using P esaR F is an upper primer, EGFP-R is a lower primer, and P is obtained by amplification by using overlap PCR technology esaR + an EGFP fragment;
the PCR reaction system is shown in Table 3 below, and the reaction conditions are as follows: pre-denaturation at 95 ℃ for 4 min; denaturation at 94 ℃ for 10 s; annealing at 60 ℃ for 30 s; extending for 2min at 68 ℃; three steps of denaturation, annealing and extension are cycled for 30 times; further extension was carried out at 68 ℃ for 10 min. Wherein the annealing temperature depends on the Tm value of the primer, and the extension time at 68 ℃ depends on the length of the amplified fragment (1 kb/min). After the PCR was completed, the product was subjected to agarose gel electrophoresis, see FIG. 2, and the three fragment modules esaI + esaR fragment and P were recovered by cutting the gel esaS + fimH + mCherry fragment and P esaR + EGFP fragment.
TABLE 2 PCR reaction System
Second, construction of recombinant plasmid
(1) Plasmid extracting body
(2) Linearization of vectors
To fragment the gene of interest (esaI + esaR, P) esaS + mCherry and P esaR + EGFP) was ligated to plasmid pUC19-PJ23119-MCS, which was digested in a double digestion reaction system (20. mu.L) of 0.1% BSA 2. mu.L, 1. mu.M buffer 2. mu.L, 0.5. mu.L each of HindIII and SacI enzymes (from TAKARA), plasmid pUC19-PJ23119-MCS 10. mu.L, sterile water 5. mu.L. The enzyme digestion reaction is carried out for 2h at 37 ℃. And (4) carrying out gel recovery after enzyme digestion for subsequent experiments.
Wherein, the buffer: 10 × Loading buffer: 0.9% SDS, 50% glycocol, 0.05% Bromophenol Blue;
Definition of enzyme activity: the reaction was carried out at 37 ℃ for 1 hour in 50. mu.L of the reaction solution, and the amount of the enzyme that completely decomposed 1. mu.g of lambda.DNA was defined as 1 activity unit (U).
(3) Construction of plasmid pUC19-PJ23119-MCS-esaI/R
The three fragments (esaI + esaR, P) esaS + mCherry and P esaR + EGFP) was ligated to the purified linear vector following the procedures described in the NEB's multiple fragment one-step cloning of the enzyme to obtain the recombinant plasmid pUC19-PJ23119-MCS-esaI/R (SEQ ID NO. 8). The one-step cloning reaction system is shown in Table 3, and after a water bath at 50 ℃ for 15 minutes, the reaction system is immediately subjected to an ice bath for 5 minutesStoring at-20 deg.C. A schematic diagram of the construction of the recombinant expression plasmid is shown in FIG. 3.
TABLE 3 Multi-fragment one-step cloning reaction System
Wherein the plasmid pUC19-PJ23119-MCS after double digestion, the purified gene fragment esaI + esaR and the purified gene fragment P esaS + fimH + mCherry, purified gene fragment P esaR + EGFP concentration 100 ng/. mu.l.
(4) Transformation and selection of recombinant plasmids
Taking out the TI competent cells, thawing the TI competent cells to be liquid on ice, and adding the competent cells and the recombinant plasmid pUC19-PJ23119-MCS-esaI/R in a ratio of 10:1v/v into a precooling centrifuge tube. The mixture was kept on ice for 30min, and heat-shocked in a water bath at 42 ℃ for 90 sec. The ice box was cooled for 3 minutes, added with 1mL LB at 37 degrees C, 200rpm culture for 1 hours, centrifugal removal of most of the supernatant heavy suspension bacteria liquid and ampicillin resistance plate. After overnight incubation in an incubator at 37 ℃, single spots on the plates were picked, 100. mu.g/mL ampicillin resistance in the shake tube was added, and then the plasmid pUC19-PJ23119-MCS-esaI/R was extracted for sequencing validation.
Third, construction of recombinant strains
After the recombinant plasmid is successfully verified, an esaI/R system-containing strain is constructed and named as Escherichia coli BL 21-R. The successfully verified plasmids are transferred into the competence of escherichia coli BL21 by the same transformation method, and a single colony is picked for colony PCR verification. The results of colony PCR experiments are shown in FIG. 4, and it can be seen that the transformation was successful.
Example 2: carrying out fluorescence microscope observation on original bacteria BL21 and modified bacteria BL21-R
(1) 100. mu.L of each of glycerol strain WT (original strain BL21) and modified strain BL21-R (strain containing esaI/R system constructed in example 1) was added to 5mL of sterilized LB liquid medium for overnight culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterial liquid obtained in the step (1) to 100mL of LB liquid medium (ampicillin resistance, 100. mu.g/mL; 3mL of 1M L-arabinose was added as appropriate for induction), and continuing the culture at 37 ℃ and 220rpm for 13 hours;
(3) and (3) sampling the bacterial liquid cultured in the step (2), and then directly observing under a fluorescence microscope, wherein the fluorescence microscope result is shown in FIG. 5, which shows that the original transformed bacterium has no luminescence, and the transformed bacterium has luminescence, and shows that the esaI/R system of the transformed bacterium BL21-R is established without errors.
Example 3: fluorescence intensity detection experiment of enzyme labeling instrument for modified bacteria BL21-R
(1) Since the original bacterium BL21 did not emit light in the fluorescence microscope observation, only the modified bacterium was detected in the fluorescence intensity detection experiment. The modified strain BL21-R (the strain containing the esaI/R system constructed in example 1) was added to a sterilized 5mL LB liquid medium in an amount of 100. mu.L for overnight culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterial liquid obtained in the step (1) to 100mL of LB liquid medium (ampicillin resistance, 100 mu g/mL), continuously culturing at 37 ℃ and 220rpm, and taking samples every 4 hours for 48 hours;
(3) the well-taken sample is diluted by 20 times by PBS buffer solution, 200 mu L of the diluted sample is added into a 96-well plate, and detection is carried out by a microplate reader at different wavelengths respectively: detecting the green fluorescence intensity of 485nm excitation wavelength and 528nm emission wavelength, and detecting the red fluorescence intensity of 587nm excitation wavelength and 610nm emission wavelength. The fluorescence intensity is shown in fig. 6, the red fluorescence (mCherry) is stronger in the early stage, the green fluorescence (EGFP) is stronger in the later stage, and the fluorescent material accords with the process of an esaI/R system and the experimental design concept, and can be applied in the next step.
Example 4: biofilm crystal violet staining experiment
1) 100. mu.L of each of glycerol strain WT (original strain BL21) and modified strain BL21-R (strain containing esaI/R system constructed in example 1) was added to 5mL of sterilized LB liquid medium for overnight culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterium liquid obtained in the step (1) to 100mL of LB liquid culture medium, and continuously culturing at 37 ℃ and 220rpm until the OD600 value of the bacterium liquid is between 0.8 and 1.2;
(3) measuring the absorbance value of 2mL of bacterial liquid under OD600, and diluting the bacterial liquid by using a sterilized LB liquid culture medium to enable the OD600 of the diluted bacterial liquid to be 1;
(4) adding 200 mu L of diluted bacterial liquid into a 96-well plate, using a liquid culture medium as a reference, and culturing at 37 ℃ for 12h, 24h and 36 h;
(5) pouring out the bacterial liquid in the 96-well plate, taking 200 mu L of 0.01M PBS buffer solution to wash for 2-3 times, and patting dry;
(6) adding 200 μ L paraformaldehyde fixing solution, fixing for 15min, pouring off, and air drying.
(7) Adding 200 μ L of 1% crystal violet solution into 96-well plate, staining for 10-20min, washing with PBS buffer solution for 2-3 times, and drying;
(8) adding 200 μ L glacial acetic acid into 96-well plate to dissolve the biofilm, gently shaking for 40min, measuring OD570nm biofilm yield, and taking average value. The crystal violet staining experiment result is shown in fig. 7, the original bacteria biofilm amount is 0.3786, the modified bacteria biofilm amount is 0.9649, and the modified bacteria biofilm amount is improved by 2.54 times, which shows that the modified strain BL21-R biofilm is obviously increased, and the biological membrane immobilization fermentation experiment can be carried out.
Example 5: application of modified bacteria BL21-R in immobilized fermentation for producing xylanase
(1) The xylanase gene xyn (derived from Thermoanaerobacterium Thermoanaerobacterium thermosaccharolyticum M5) was replaced in the position of the EGFP gene.
Alternatively, EGFP of the recombinant plasmid is cut off by using an enzyme cleavage site and then xyn is connected by one-step cloning by using a one-step cloning kit C112 of Novozam, and the specific steps are similar to the step (3) of the example 1 to obtain the strain BL 21-R-xyn.
Meanwhile, a strain WT-xyn only containing xyn genes is constructed (the method is the same as the method, and the used plasmid is an empty plasmid PUC19 without esaI/R system).
(2) Immobilizing the bacteria obtained in the step (1) for fermentation to produce xylanase
WT-xyn and BL21-R-xyn were removed from a freezer at-80 ℃ and 5mL of LB medium was prepared in tubes, one bottle containing 100. mu.g/mL ampicillin at 1% inoculum size. Culturing in a shaker at 37 deg.C for 12h at 200rpm to obtain bacterial liquid.
The resulting bacterial solution was diluted to OD 0.1 and inoculated into 100mL LB fermentation medium (5 g square cotton fibers were placed in the medium in advance), and cultured in a shaker at 37 ℃ for 36h at 200 and 220 rpm.
Wherein, the LB fermentation medium: 30g/L of glucose, 0.8g/L of sodium chloride, 20g/L of ammonium sulfate, 2g/L of anhydrous potassium dihydrogen phosphate, 0.8g/L of magnesium sulfate heptahydrate, 0.02g/L of manganese sulfate pentahydrate, 0.02g/L of ferric sulfate heptahydrate, 10.002g/L of vitamin B, 1g/L of yeast powder and 15g/L of calcium carbonate.
The detection method comprises the following steps: the xylanase activity is determined by a dinitrosalicylic acid method (DNS), dinitrosalicylic acid and reducing sugar can generate oxidation-reduction reaction to generate 3-amino-5-nitro salicylic acid, the product is brownish red under boiling condition, and the color depth is in a proportional relation with the content of the reducing sugar within a certain concentration range. The reaction process is as follows: 1mL of enzyme solution (diluted by a certain amount if necessary) and 1mL of 1% xylan (dissolved in PBS buffer solution with pH 6.0) were reacted in a water bath at 55 ℃ for 10min, then 2mL of DNS solution was added, and the mixture was subjected to a boiling water bath for 5min to obtain a volume of 25mL, and A540 was measured. Definition of enzyme activity (U): the amount of enzyme required to produce 1. mu.M xylose per minute.
The enzyme activity test result is shown in figure 8, the enzyme activity of the original strain WT-xyn is measured to be 0.55U/mg, the enzyme activity of the modified strain BL21-R-xyn is measured to be 0.97U/mg, and the enzyme activity of the modified strain is improved by 1.76 times.
The invention provides an escherichia coli genetic engineering bacterium containing an esaI/R quorum sensing system, and a construction method and application thereof, the above description is only a preferred embodiment of the invention, and it should be noted that, for a person skilled in the art, a plurality of improvements and modifications can be made without departing from the principle of the invention, and these improvements and modifications should also be regarded as the protection scope of the invention. All the components not specified in the present embodiment can be realized by the prior art.
Sequence listing
<110> Nanjing university of industry
<120> method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) to quorum sensing dynamic regulation and control system
<160> 23
<170> SIPOSequenceListing 1.0
<210> 1
<211> 606
<212> DNA
<213> esaI
<400> 1
atgatcgtac aaattggtcg gcgcgaagag ttcgataaaa aactgctggg cgagatgcac 60
aagttgcgtg ctcaagtgtt caaggagcgc aaaggctggg acgttagtgt catcgacgag 120
atggaaatcg atggttatga cgcactcagt ccttattaca tgttgatcca ggaagatact 180
cctgaagccc aggttttcgg ttgctggcga attctcgata ccactggccc ctacatgctg 240
aagaacacct tcccggagct tctgcacggc aaggaagcgc cttgctcgcc gcacatctgg 300
gaactcagcc gtttcgccat caactctgga cagaaaggct cgctgggctt ttccgactgt 360
acgctggagg cgatgcgcgc gctggcccgc tacagcctgc agaacgacat ccagacgctg 420
gtgacggtaa ccaccgtagg cgtggagaag atgatgatcc gtgccggcct ggacgtatcg 480
cgcttcggtc cgcacctgaa gatcggcatc gagcgcgcgg tggccttgcg catcgaactc 540
aatgccaaga cccagatcgc gctttacggg ggagtgctgg tggaacagcg actggcggtt 600
tcatga 606
<210> 2
<211> 720
<212> DNA
<213> esaR
<400> 2
atggccttgg ttgacggttt tcttgagctg gaacgctcaa gtggaaaatt ggagtggagc 60
gccatcctgc agaagatggc gagcgacctt ggattctcga agatcctgtt cggcctgttg 120
cctaaggaca gccaggacta cgagaacgcc ttcatcgtcg gcaactaccc ggccgcctgg 180
cgcgagcatt acgaccgggc tggctacgcg cgggtcgacc cgacggtcag tcactgtacc 240
cagagcgtac tgccgatttt ctgggaaccg tccatctacc agacgcgaaa gcagcacgag 300
ttcttcgagg aagcctcggc cgccggcctg gtgtatgggc tgaccatgcc gctgcatggt 360
gctcgcggcg aactcggcgc gctgagcctc agcgtggaag cggaaaaccg ggccgaggcc 420
aaccgtttca tggagtcggt cctgccgacc ctgtggatgc tcaaggacta cgcactgcag 480
agcggtgccg gactggcctt cgaacatccg gtcagcaaac cggtggttct gaccagccgg 540
gagaaggaag tgttgcagtg gtgcgccatc ggcaagacca gttgggagat atcggttatc 600
tgcaactgct cggaagccaa tgtgaacttc catatgggaa atattcggcg gaagttcggt 660
gtgacctccc gccgcgtagc ggccattatg gccgttaatt tgggtcttat tactctctga 720
<210> 3
<211> 184
<212> DNA
<213> PesaS
<400> 3
gctcacaaca gtgtaagcgt atccgttatt gtttgatttt caaggaaaaa agaaaacatt 60
caggctccat gctgcttctt ttacttaacg tggacttaac ctgcactata gtacaggcaa 120
gatgatactt aagagtaact tacaatgaat cattcagagg ttacaatggc ttcagttgtt 180
tagc 184
<210> 4
<211> 102
<212> DNA
<213> PesaR
<400> 4
ttgtaacctc tgaatgattc attgtaagtt actcttaagt atcatcttgc ctgtactata 60
gtgcaggtta agtccacgtt aagtaaaaga agcagcggat cc 102
<210> 5
<211> 717
<212> DNA
<213> mCherry
<400> 5
atggtgagca agggcgagga ggataacatg gccatcatca aggagttcat gcgcttcaag 60
gtgcacatgg agggctccgt gaacggccac gagttcgaga tcgagggcga gggcgagggc 120
cgcccctacg agggcaccca gaccgccaag ctgaaggtga ccaagggtgg ccccctgccc 180
ttcgcctggg acatcctgtc ccctcagttc atgtacggct ccaaggccta cgtgaagcac 240
cccgccgaca tccccgacta cttgaagctg tccttccccg agggcttcaa gtgggagcgc 300
gtgatgaact tcgaggacgg cggcgtggtg accgtgaccc aggactcctc cctgcaggac 360
ggcgagttca tctacaaggt gaagctgcgc ggcaccaact tcccctccga cggccccgta 420
atgcagaaga agaccatggg ctgggaggcc tcctccgagc ggatgtaccc cgaggacggc 480
gccctgaagg gcgagatcaa gcagaggctg aagctgaagg acggcggcca ctacgacgct 540
gaggtcaaga ccacctacaa ggccaagaag cccgtgcagc tgcccggcgc ctacaacgtc 600
aacatcaagt ttctagagga catcacctcc cacaacgagg actacaccat cgtggaacag 660
tacgaacgcg ccgagggccg ccactccacc ggcggcatgg acgagctgta caagtaa 717
<210> 6
<211> 720
<212> DNA
<213> EGFP
<400> 6
atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 60
ggcgacgtaa acggccacaa gttcagcgtg tccggcgagg gcgagggcga tgccacctac 120
ggcaagctga ccctgaagtt catctgcacc accggcaagc tgcccgtgcc ctggcccacc 180
ctcgtgacca ccctgaccta cggcgtgcag tgcttcagcc gctaccccga ccacatgaag 240
cagcacgact tcttcaagtc cgccatgccc gaaggctacg tccaggagcg caccatcttc 300
ttcaaggacg acggcaacta caagacccgc gccgaggtga agttcgaggg cgacaccctg 360
gtgaaccgca tcgagctgaa gggcatcgac ttcaaggagg acggcaacat cctggggcac 420
aagctggagt acaactacaa cagccacaac gtctatatca tggccgacaa gcagaagaac 480
ggcatcaagg tgaacttcaa gatccgccac aacatcgagg acggcagcgt gcagctcgcc 540
gaccactacc agcagaacac ccccatcggc gacggccccg tgctgctgcc cgacaaccac 600
tacctgagca cccagtccgc cctgagcaaa gaccccaacg agaagcgcga tcacatggtc 660
ctgctggagt tcgtgaccgc cgccgggatc actctcggca tggacgagct gtacaagtaa 720
<210> 7
<211> 903
<212> DNA
<213> fimH
<400> 7
atgaaacgag ttattaccct gtttgctgta ctgctgatgg gctggtcggt aaatgcctgg 60
tcattcgcct gtaaaaccgc caatggtacc gctatcccta ttggcggtgg cagcgccaat 120
gtttatgtaa accttgcgcc cgtcgtgaat gtggggcaaa acctggtcgt ggatctttcg 180
acgcaaatct tttgccataa cgattatccg gaaaccatta cagactatgt cacactgcaa 240
cgaggctcgg cttatggcgg cgtgttatct aatttttccg ggaccgtaaa atatagtggc 300
agtagctatc catttcctac caccagcgaa acgccgcgcg ttgtttataa ttcgagaacg 360
gataagccgt ggccggtggc gctttatttg acgcctgtga gcagtgcggg cggggtggcg 420
attaaagctg gctcattaat tgccgtgctt attttgcgac agaccaacaa ctataacagc 480
gatgatttcc agtttgtgtg gaatatttac gccaataatg atgtggtggt gcctactggc 540
ggctgcgatg tttctgctcg tgatgtcacc gttactctgc cggactaccc tggttcagtg 600
ccaattcctc ttaccgttta ttgtgcgaaa agccaaaacc tggggtatta cctctccggc 660
acaaccgcag atgcgggcaa ctcgattttc accaataccg cgtcgttttc acctgcacag 720
ggcgtcggcg tacagttgac gcgcaacggt acgattattc cagcgaataa cacggtatcg 780
ttaggagcag tagggacttc ggcggtgagt ctgggattaa cggcaaatta tgcacgtacc 840
ggagggcagg tgactgcagg gaatgtgcaa tcgattattg gcgtgacttt tgtttatcaa 900
taa 903
<210> 8
<211> 6959
<212> DNA
<213> pUC19-PJ23119-MCS-esaI/R
<400> 8
gcgcccaata cgcaaaccgc ctctccccgc gcgttggccg attcattaat gcagctggca 60
cgacaggttt cccgactgga aagcgggcag tgagcgcaac gcaattaatg tgagttagct 120
cactcattag gcaccccagg cttgacagct agctcagtcc taggtataat actagttttc 180
acacaggaaa cagctatgac catgattacg ccaagcttaa gaaaccaatt gtccatattg 240
catcagacat tgccgtcact gcgtctttta ctggcacttc tcgctaacca aaccggtaac 300
cccgcttatt aaaagcattc tgtaacaaag cgggaccaaa gccatgacaa aaacgcgtaa 360
caaaagtgtc tataatcacg gcagaaaagt ccacattgat tatttgcacg gcgtcacact 420
ttgctatgcc atagcatttt tatccataag attagcggat cctacctgac gctttttatc 480
gcaactctct actgtttctc catgtcgaca tgatcgtaca aattggtcgg cgcgaagagt 540
tcgataaaaa actgctgggc gagatgcaca agttgcgtgc tcaagtgttc aaggagcgca 600
aaggctggga cgttagtgtc atcgacgaga tggaaatcga tggttatgac gcactcagtc 660
cttattacat gttgatccag gaagatactc ctgaagccca ggttttcggt tgctggcgaa 720
ttctcgatac cactggcccc tacatgctga agaacacctt cccggagctt ctgcacggca 780
aggaagcgcc ttgctcgccg cacatctggg aactcagccg tttcgccatc aactctggac 840
agaaaggctc gctgggcttt tccgactgta cgctggaggc gatgcgcgcg ctggcccgct 900
acagcctgca gaacgacatc cagacgctgg tgacggtaac caccgtaggc gtggagaaga 960
tgatgatccg tgccggcctg gacgtatcgc gcttcggtcc gcacctgaag atcggcatcg 1020
agcgcgcggt ggccttgcgc atcgaactca atgccaagac ccagatcgcg ctttacgggg 1080
gagtgctggt ggaacagcga ctggcggttt catgataatg tgagttagct cactcattag 1140
gcaccccagg cttgacagct agctcagtcc taggtataat actagtatgg ccttggttga 1200
cggttttctt gagctggaac gctcaagtgg aaaattggag tggagcgcca tcctgcagaa 1260
gatggcgagc gaccttggat tctcgaagat cctgttcggc ctgttgccta aggacagcca 1320
ggactacgag aacgccttca tcgtcggcaa ctacccggcc gcctggcgcg agcattacga 1380
ccgggctggc tacgcgcggg tcgacccgac ggtcagtcac tgtacccaga gcgtactgcc 1440
gattttctgg gaaccgtcca tctaccagac gcgaaagcag cacgagttct tcgaggaagc 1500
ctcggccgcc ggcctggtgt atgggctgac catgccgctg catggtgctc gcggcgaact 1560
cggcgcgctg agcctcagcg tggaagcgga aaaccgggcc gaggccaacc gtttcatgga 1620
gtcggtcctg ccgaccctgt ggatgctcaa ggactacgca ctgcagagcg gtgccggact 1680
ggccttcgaa catccggtca gcaaaccggt ggttctgacc agccgggaga aggaagtgtt 1740
gcagtggtgc gccatcggca agaccagttg ggagatatcg gttatctgca actgctcgga 1800
agccaatgtg aacttccata tgggaaatat tcggcggaag ttcggtgtga cctcccgccg 1860
cgtagcggcc attatggccg ttaatttggg tcttattact ctctgagcat gcgctcacaa 1920
cagtgtaagc gtatccgtta ttgtttgatt ttcaaggaaa aaagaaaaca ttcaggctcc 1980
atgctgcttc ttttacttaa cgtggactta acctgcacta tagtacaggc aagatgatac 2040
ttaagagtaa cttacaatga atcattcaga ggttacaatg gcttcagttg tttagcgtcg 2100
acatgaaacg agttattacc ctgtttgctg tactgctgat gggctggtcg gtaaatgcct 2160
ggtcattcgc ctgtaaaacc gccaatggta ccgctatccc tattggcggt ggcagcgcca 2220
atgtttatgt aaaccttgcg cccgtcgtga atgtggggca aaacctggtc gtggatcttt 2280
cgacgcaaat cttttgccat aacgattatc cggaaaccat tacagactat gtcacactgc 2340
aacgaggctc ggcttatggc ggcgtgttat ctaatttttc cgggaccgta aaatatagtg 2400
gcagtagcta tccatttcct accaccagcg aaacgccgcg cgttgtttat aattcgagaa 2460
cggataagcc gtggccggtg gcgctttatt tgacgcctgt gagcagtgcg ggcggggtgg 2520
cgattaaagc tggctcatta attgccgtgc ttattttgcg acagaccaac aactataaca 2580
gcgatgattt ccagtttgtg tggaatattt acgccaataa tgatgtggtg gtgcctactg 2640
gcggctgcga tgtttctgct cgtgatgtca ccgttactct gccggactac cctggttcag 2700
tgccaattcc tcttaccgtt tattgtgcga aaagccaaaa cctggggtat tacctctccg 2760
gcacaaccgc agatgcgggc aactcgattt tcaccaatac cgcgtcgttt tcacctgcac 2820
agggcgtcgg cgtacagttg acgcgcaacg gtacgattat tccagcgaat aacacggtat 2880
cgttaggagc agtagggact tcggcggtga gtctgggatt aacggcaaat tatgcacgta 2940
ccggagggca ggtgactgca gggaatgtgc aatcgattat tggcgtgact tttgtttatc 3000
aataaatggt gagcaagggc gaggaggata acatggccat catcaaggag ttcatgcgct 3060
tcaaggtgca catggagggc tccgtgaacg gccacgagtt cgagatcgag ggcgagggcg 3120
agggccgccc ctacgagggc acccagaccg ccaagctgaa ggtgaccaag ggtggccccc 3180
tgcccttcgc ctgggacatc ctgtcccctc agttcatgta cggctccaag gcctacgtga 3240
agcaccccgc cgacatcccc gactacttga agctgtcctt ccccgagggc ttcaagtggg 3300
agcgcgtgat gaacttcgag gacggcggcg tggtgaccgt gacccaggac tcctccctgc 3360
aggacggcga gttcatctac aaggtgaagc tgcgcggcac caacttcccc tccgacggcc 3420
ccgtaatgca gaagaagacc atgggctggg aggcctcctc cgagcggatg taccccgagg 3480
acggcgccct gaagggcgag atcaagcaga ggctgaagct gaaggacggc ggccactacg 3540
acgctgaggt caagaccacc tacaaggcca agaagcccgt gcagctgccc ggcgcctaca 3600
acgtcaacat caagtttcta gaggacatca cctcccacaa cgaggactac accatcgtgg 3660
aacagtacga acgcgccgag ggccgccact ccaccggcgg catggacgag ctgtacaagt 3720
aattgtaacc tctgaatgat tcattgtaag ttactcttaa gtatcatctt gcctgtacta 3780
tagtgcaggt taagtccacg ttaagtaaaa gaagcagcgg atccctcgag atggtgagca 3840
agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac ggcgacgtaa 3900
acggccacaa gttcagcgtg tccggcgagg gcgagggcga tgccacctac ggcaagctga 3960
ccctgaagtt catctgcacc accggcaagc tgcccgtgcc ctggcccacc ctcgtgacca 4020
ccctgaccta cggcgtgcag tgcttcagcc gctaccccga ccacatgaag cagcacgact 4080
tcttcaagtc cgccatgccc gaaggctacg tccaggagcg caccatcttc ttcaaggacg 4140
acggcaacta caagacccgc gccgaggtga agttcgaggg cgacaccctg gtgaaccgca 4200
tcgagctgaa gggcatcgac ttcaaggagg acggcaacat cctggggcac aagctggagt 4260
acaactacaa cagccacaac gtctatatca tggccgacaa gcagaagaac ggcatcaagg 4320
tgaacttcaa gatccgccac aacatcgagg acggcagcgt gcagctcgcc gaccactacc 4380
agcagaacac ccccatcggc gacggccccg tgctgctgcc cgacaaccac tacctgagca 4440
cccagtccgc cctgagcaaa gaccccaacg agaagcgcga tcacatggtc ctgctggagt 4500
tcgtgaccgc cgccgggatc actctcggca tggacgagct gtacaagtaa gagctcgaat 4560
tcactggccg tcgttttaca acgtcgtgac tgggaaaacc ctggcgttac ccaacttaat 4620
cgccttgcag cacatccccc tttcgccagc tggcgtaata gcgaagaggc ccgcaccgat 4680
cgcccttccc aacagttgcg cagcctgaat ggcgaatggc gcctgatgcg gtattttctc 4740
cttacgcatc tgtgcggtat ttcacaccgc atatggtgca ctctcagtac aatctgctct 4800
gatgccgcat agttaagcca gccccgacac ccgccaacac ccgctgacgc gccctgacgg 4860
gcttgtctgc tcccggcatc cgcttacaga caagctgtga ccgtctccgg gagctgcatg 4920
tgtcagaggt tttcaccgtc atcaccgaaa cgcgcgagac gaaagggcct cgtgatacgc 4980
ctatttttat aggttaatgt catgataata atggtttctt agacgtcagg tggcactttt 5040
cggggaaatg tgcgcggaac ccctatttgt ttatttttct aaatacattc aaatatgtat 5100
ccgctcatga gacaataacc ctgataaatg cttcaataat attgaaaaag gaagagtatg 5160
agtattcaac atttccgtgt cgcccttatt cccttttttg cggcattttg ccttcctgtt 5220
tttgctcacc cagaaacgct ggtgaaagta aaagatgctg aagatcagtt gggtgcacga 5280
gtgggttaca tcgaactgga tctcaacagc ggtaagatcc ttgagagttt tcgccccgaa 5340
gaacgttttc caatgatgag cacttttaaa gttctgctat gtggcgcggt attatcccgt 5400
attgacgccg ggcaagagca actcggtcgc cgcatacact attctcagaa tgacttggtt 5460
gagtactcac cagtcacaga aaagcatctt acggatggca tgacagtaag agaattatgc 5520
agtgctgcca taaccatgag tgataacact gcggccaact tacttctgac aacgatcgga 5580
ggaccgaagg agctaaccgc ttttttgcac aacatggggg atcatgtaac tcgccttgat 5640
cgttgggaac cggagctgaa tgaagccata ccaaacgacg agcgtgacac cacgatgcct 5700
gtagcaatgg caacaacgtt gcgcaaacta ttaactggcg aactacttac tctagcttcc 5760
cggcaacaat taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg 5820
gcccttccgg ctggctggtt tattgctgat aaatctggag ccggtgagcg tgggtctcgc 5880
ggtatcattg cagcactggg gccagatggt aagccctccc gtatcgtagt tatctacacg 5940
acggggagtc aggcaactat ggatgaacga aatagacaga tcgctgagat aggtgcctca 6000
ctgattaagc attggtaact gtcagaccaa gtttactcat atatacttta gattgattta 6060
aaacttcatt tttaatttaa aaggatctag gtgaagatcc tttttgataa tctcatgacc 6120
aaaatccctt aacgtgagtt ttcgttccac tgagcgtcag accccgtaga aaagatcaaa 6180
ggatcttctt gagatccttt ttttctgcgc gtaatctgct gcttgcaaac aaaaaaacca 6240
ccgctaccag cggtggtttg tttgccggat caagagctac caactctttt tccgaaggta 6300
actggcttca gcagagcgca gataccaaat actgttcttc tagtgtagcc gtagttaggc 6360
caccacttca agaactctgt agcaccgcct acatacctcg ctctgctaat cctgttacca 6420
gtggctgctg ccagtggcga taagtcgtgt cttaccgggt tggactcaag acgatagtta 6480
ccggataagg cgcagcggtc gggctgaacg gggggttcgt gcacacagcc cagcttggag 6540
cgaacgacct acaccgaact gagataccta cagcgtgagc tatgagaaag cgccacgctt 6600
cccgaaggga gaaaggcgga caggtatccg gtaagcggca gggtcggaac aggagagcgc 6660
acgagggagc ttccaggggg aaacgcctgg tatctttata gtcctgtcgg gtttcgccac 6720
ctctgacttg agcgtcgatt tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac 6780
gccagcaacg cggccttttt acggttcctg gccttttgct ggccttttgc tcacatgttc 6840
tttcctgcgt tatcccctga ttctgtggat aaccgtatta ccgcctttga gtgagctgat 6900
accgctcgcc gcagccgaac gaccgagcgc agcgagtcag tgagcgagga agcggaaga 6959
<210> 9
<211> 47
<212> DNA
<213> fimH-F
<400> 9
caatggcttc agttgtttag cgtcgacatg aaacgagtta ttaccct 47
<210> 10
<211> 47
<212> DNA
<213> fimH-R
<400> 10
atcctcctcg cccttgctca ccatttattg ataaacaaaa gtcacgc 47
<210> 11
<211> 50
<212> DNA
<213> esaI-F
<400> 11
gcaactctct actgtttctc catgtcgaca tgatcgtaca aattggtcgg 50
<210> 12
<211> 65
<212> DNA
<213> esaI-R
<400> 12
gtcaaccaag gccatactag tattatacct aggactgagc tagctgtcaa tcatgaaacc 60
gccag 65
<210> 13
<211> 65
<212> DNA
<213> esaR-F
<400> 13
ctggcggttt catgattgac agctagctca gtcctaggta taatactagt atggccttgg 60
ttgac 65
<210> 14
<211> 37
<212> DNA
<213> esaR-R
<400> 14
gcatgctcag agagtaataa gacccaaatt aacggcc 37
<210> 15
<211> 46
<212> DNA
<213> PesaS-F
<400> 15
tgggtcttat tactctctga gcatgcgctc acaacagtgt aagcgt 46
<210> 16
<211> 47
<212> DNA
<213> PesaS-R
<400> 16
agggtaataa ctcgtttcat gtcgacgcta aacaactgaa gccattg 47
<210> 17
<211> 42
<212> DNA
<213> PesaR-F
<400> 17
ctacaacgtc aacatcaagt ttctagagga catcacctcc ca 42
<210> 18
<211> 36
<212> DNA
<213> PesaR-R
<400> 18
gagctgtaca agtaactcga gggatccgct gcttct 36
<210> 19
<211> 47
<212> DNA
<213> mcherry-F
<400> 19
gcgtgacttt tgtttatcaa taaatggtga gcaagggcga ggaggat 47
<210> 20
<211> 26
<212> DNA
<213> mcherry-R
<400> 20
tctagattac ttgtacagct cgtcca 26
<210> 21
<211> 47
<212> DNA
<213> EGFP-F
<400> 21
agaagcagcg gatccctcga gatggtgagc aagggcgagg agctgtt 47
<210> 22
<211> 50
<212> DNA
<213> EGFP-R
<400> 22
cgacggccag tgaattcgag ctcttacttg tacagctcgt ccatgccgag 50
<210> 23
<211> 1242
<212> DNA
<213> xyn
<400> 23
atgaatgcgg atgctgcaga taaattaaaa caccgcaaag gaatcgccaa aataaagtta 60
gttaagaaag atggttcacc tataaaagat gcagaagtcg ctgtatctca ggtgaagcat 120
aaatttttat ttggttgtgg agcatttgat tctcttcctc ttgccaatgg tgaattgaaa 180
gaaaatgata aagaaaaaat tgaagaccgt tttgagaaat tttttgactt atttaactat 240
gctacgattc cattttattg gggcaggttc gagcctgaaa aaggaaagcc agacacaaat 300
agactcaaaa aggcttcaga atggcttgta tcaaaaggtt gccttgtaaa aggccatcca 360
ctttgctggc atactgtaac agcaccttgg cttttagata tgaacaatga agacatatta 420
aaggctcagc tatcccgcat aaaacgtgaa gtaagcgatt ttaaaggatt agtgaatata 480
tgggatgtaa taaatgaagt tgtcatcatg cctatttttg ataaatacga caatggaata 540
accaggatat gcaaagaatt aggccgtatt cgcctcgtaa aagaagtttt taatgaagct 600
aaaaaagcta atcctgaagc agttctcctt ataaatgact ttaatacatc aatttcatac 660
gaaatactca tagaaggatg ccttgaagct ggaatcccta ttgatgccat aggaattcag 720
tcacacatgc atcaaggata ttggggagtt gaaaaaactt tagaagtact tgaaagattt 780
tcgcatttca acattccatt gcattttaca gaaaacacat tattatcagg gcatttgatg 840
ccacctgaaa tagaagactt aaatgactac cagataaggg attggccttc aacacctgat 900
ggtgaagaac gacaagcgat ggaaatagta cagcattaca aaactctttt ttcacatcca 960
atggtagaat caattacgtg gtggaatttt tgtgatgaaa atgcatggct tggtgcacca 1020
gcaggtcttt tacgccgtga caattcatgc aaaccatcat attacgaatt aaaaaagctt 1080
ataaaagatg aatggtggac acatcctaca cgtcttgtca caagtaacac aggcgaattt 1140
gaatttacag gtttcttagg cgaatacgaa ttagtcatta gcgataaaag gttttacttt 1200
acccttgata aaaacagcac aacaattgaa atcacgattt aa 1242
Claims (10)
1. An escherichia coli genetic engineering bacterium is characterized in that pUC19-PJ23119-MCS plasmid containing esaI/R system is introduced into escherichia coli BL21 and combined with adhesion gene fimH.
2. The escherichia coli genetically engineered bacterium of claim 1, wherein the gene contained in the esaI/R system is a transcription regulatory factor having a nucleotide sequence shown in SEQ ID No.1 and SEQ ID No.2, respectively: esaI, esaR; the nucleotide sequences of the promoter are respectively shown as SEQ ID NO.3 and SEQ ID NO. 4: p esaS 、P esaR (ii) a The nucleotide sequences of the reporter genes are respectively shown as SEQ ID NO.5 and SEQ ID NO. 6: red fluorescent protein mCherry, green fluorescent protein EGFP.
3. The engineered Escherichia coli strain of claim 1, wherein the nucleotide sequence of fimH is represented by SEQ ID NO. 7.
4. The method for constructing the Escherichia coli genetically engineered bacterium of any one of claims 1 to 3, comprising the steps of:
(1) amplifying to obtain esaI and esaR genes by using pseudomonas aeruginosa genome DNA as a template; the gene P is synthesized by general biosynthesis esaS 、P esaR The PUC19 plasmid is used as a template to obtain P through amplification esaS 、P esaR A gene; amplifying by taking a plasmid pET28a-mCherry as a template to obtain an mCheerry gene; amplifying by taking the plasmid pET-28a-EGFP as a template to obtain an EGFP gene;
(2) taking the fragment obtained in the step (1) as a template, and carrying out overlap PCR amplification to obtain an esaI + esaR fragment and P esaS + fimH + mCherry fragment, P esaR + an EGFP fragment;
(3) cloning the gene fragment obtained in the step (2) between Hind III and Sac I restriction sites of plasmid pUC19-PJ23119-MCS to obtain recombinant plasmid pUC19-PJ23119-MCS-esaI/R, wherein the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 8;
(4) transforming the recombinant plasmid obtained in the step (3) into an escherichia coli T1 competence, and extracting, purifying and recovering the recombinant plasmid from escherichia coli T1;
(5) and (3) transforming the recombinant plasmid extracted in the step (4) into the competence of escherichia coli BL21 to obtain the escherichia coli genetic engineering bacteria.
5. The method of claim 4, wherein in step (1), primers for amplifying esaI and esaR genes are esaI-F, esaI-R, esaR-F, esaR-R with nucleotide sequences shown in SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO.14, respectively.
6. The method of claim 4, wherein in step (1), P is amplified esaS 、P esaR The primers of the gene are P with nucleotide sequences shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO.18 respectively esaS -F、P esaS -R、P esaR -F、P esaR -R。
7. The method of claim 4, wherein in the step (1), primers for amplifying mCherry and EGFP genes are mCherry-F, mCherry-R, EGFP-F, EGFP-R with the nucleotide sequences shown in SEQ ID NO.19, SEQ ID NO.20, SEQ ID NO.21 and SEQ ID NO.22, respectively.
8. The use of the genetically engineered Escherichia coli of any one of claims 1 to 3 in the production of xylanase.
9. The application of claim 8, wherein the xylanase is produced by replacing xylanase gene with xylanase gene shown in SEQ ID NO.23, and inoculating the strain to fermentation medium.
10. The use of claim 9, wherein the fermentation medium comprises 30g/L glucose, 0.8g/L sodium chloride, 20-22g/L ammonium sulfate, 2g/L anhydrous potassium dihydrogen phosphate, 0.8g/L magnesium sulfate heptahydrate, 0.02g/L manganese sulfate pentahydrate, 0.02g/L iron sulfate heptahydrate, 10.002g/L vitamin B, 1g/L yeast powder and 15-30g/L calcium carbonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210713019.5A CN114836362A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210713019.5A CN114836362A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114836362A true CN114836362A (en) | 2022-08-02 |
Family
ID=82573398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210713019.5A Pending CN114836362A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114836362A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115745151A (en) * | 2022-12-06 | 2023-03-07 | 福瑞莱环保科技(深圳)股份有限公司 | Solid-liquid separation process based on dynamic biological filter membrane |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119162A1 (en) * | 2001-07-05 | 2003-06-26 | Churchill Mair E.A. | Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom |
CN104862329A (en) * | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-threonine genetic engineering production bacteria |
CN110079567A (en) * | 2019-05-13 | 2019-08-02 | 南京工业大学 | Application of recombinant escherichia coli for overexpression of fimH gene in fermentation production of amino acid |
CN110527693A (en) * | 2019-06-28 | 2019-12-03 | 南京农业大学 | It is a kind of based on the gene switching system of pseudomonas aeruginosa intervention school-based and its application |
-
2022
- 2022-06-22 CN CN202210713019.5A patent/CN114836362A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119162A1 (en) * | 2001-07-05 | 2003-06-26 | Churchill Mair E.A. | Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom |
CN104862329A (en) * | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-threonine genetic engineering production bacteria |
CN110079567A (en) * | 2019-05-13 | 2019-08-02 | 南京工业大学 | Application of recombinant escherichia coli for overexpression of fimH gene in fermentation production of amino acid |
CN110527693A (en) * | 2019-06-28 | 2019-12-03 | 南京农业大学 | It is a kind of based on the gene switching system of pseudomonas aeruginosa intervention school-based and its application |
Non-Patent Citations (1)
Title |
---|
郑义等: "群体感应系统在合成生物学中的应用", 《中国生物工程杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115745151A (en) * | 2022-12-06 | 2023-03-07 | 福瑞莱环保科技(深圳)股份有限公司 | Solid-liquid separation process based on dynamic biological filter membrane |
CN115745151B (en) * | 2022-12-06 | 2024-03-26 | 福瑞莱环保科技(深圳)股份有限公司 | Solid-liquid separation process based on dynamic biological filter membrane |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111893128A (en) | Method for preparing recombinant eukaryotic mRNA by using prokaryotic transcription system and application thereof | |
CN109661403A (en) | The yeast strain for the engineering that the glucoamylase polypeptide of leader sequence modification and the biologic with enhancing generate | |
US10961513B2 (en) | Methods and compositions for recombinase-based genetic diversification | |
KR102357193B1 (en) | Compositions and Methods for Robust Dynamic Metabolic Modulation | |
KR20130138866A (en) | Recombinant microorganisms and methods of use thereof | |
KR20130020842A (en) | High throughput screening of genetically modified photosynthetic organisms | |
EP3497605A1 (en) | Cell-free sensor systems | |
CN114836362A (en) | Method for improving immobilized fermentation of escherichia coli by applying fimH (fimH) in quorum sensing dynamic regulation and control system | |
CN106636168A (en) | Method for regulating and controlling synthesis of clostridium acetobutylicum extracellular polymer | |
Booth et al. | The history of Salpingoeca rosetta as a model for reconstructing animal origins | |
CN108992665B (en) | Cervical cancer therapeutic vaccine based on recombinant attenuated listeria monocytogenes | |
CN113302303A (en) | Modified filamentous fungal host cells | |
CN110195075B (en) | Streptococcus gene induction expression system and application thereof | |
Lo Sciuto et al. | Generation of stable and unmarked conditional mutants in Pseudomonas aeruginosa | |
CN109010819B (en) | Application of recombinant attenuated listeria in preparation of cervical cancer therapeutic vaccine | |
Huo et al. | Identifying amino acid overproducers using rare-codon-rich markers | |
CN107119065B (en) | It is a kind of for producing the recombinant plasmid, engineering strain and method of piperidinecarboxylic acid | |
CN109837277A (en) | A kind of CPGK chimeric promoters, gland relevant viral vector and its application | |
KR20220164007A (en) | Methods and compositions for producing xylitol from xylose using dynamic metabolic control | |
Chen et al. | Knockout of a highly GC‐rich gene in Burkholderia pyrrocinia by recombineering with freeze‐thawing transformation | |
CN108070602B (en) | Molecular modification method for reducing and delaying sporulation of bacillus | |
CN112322590A (en) | Recombinant goat pox virus co-expressing B2L and F1L proteins | |
JP2003274958A (en) | Dual vector having selective functions of multicopy or genome insertion | |
KR102173211B1 (en) | Yeast strain with glucose and xylose co-utilization capacity | |
CN108823232A (en) | A kind of AIDS vaccine and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |